Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
British Journal of Clinical Pharmacology
|
November 5, 2023
Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?
Elena Peruzzi, Rossana Roncato, Elena De Mattia, et al.
International Journal of Cardiology
|
August 23, 2018
HF progression among outpatients with HF in a community setting
Annamaria Iorio, Federico Rea, Giulia Barbati, et al.
Fertility and Sterility
|
August 21, 2010
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study
Gianfranco Scarselli, Gianni Bargelli, Gian Luigi Taddei, et al.
Pediatric Dermatology
|
April 17, 2015
Epidemiology of Frequently Occurring Skin Diseases in Italian Children from 2006 to 2012: A Retrospective, Population-Based Study
Anna Cantarutti, Daniele Donà, Federica Visentin, et al.
Therapeutic Drug Monitoring
|
February 17, 2024
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method
Bianca Posocco, Martina Zanchetta, Marco Orleni, et al.
Journal of Minimally Invasive Gynecology
|
October 20, 2009
Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report
Massimiliano Fambrini, Gianni Bargelli, Elena Peruzzi, et al.
Frontiers in Pharmacology
|
September 23, 2024
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions
Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, et al.
International Journal of Molecular Sciences
|
October 16, 2024
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring
Eleonora Cecchin, Marco Orleni, Sara Gagno, et al.
Menopause (New York, N.Y.)
|
June 7, 2003
Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women
Alessandro Rubinacci, Elena Peruzzi, Alberto Bacchi Modena, et al.
International Journal of Cancer
|
June 10, 2026
DPYD and UGT1A1 Genotype-Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant-Specific Impact on Treatment Intensity and Toxicity
Martina Gambron, Elena Peruzzi, Samantha Perfler, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
British Journal of Clinical Pharmacology
|
November 5, 2023
Implementation of pre-emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?
Elena Peruzzi, Rossana Roncato, Elena De Mattia, et al.
International Journal of Cardiology
|
August 23, 2018
HF progression among outpatients with HF in a community setting
Annamaria Iorio, Federico Rea, Giulia Barbati, et al.
Fertility and Sterility
|
August 21, 2010
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study
Gianfranco Scarselli, Gianni Bargelli, Gian Luigi Taddei, et al.
Pediatric Dermatology
|
April 17, 2015
Epidemiology of Frequently Occurring Skin Diseases in Italian Children from 2006 to 2012: A Retrospective, Population-Based Study
Anna Cantarutti, Daniele Donà, Federica Visentin, et al.
Therapeutic Drug Monitoring
|
February 17, 2024
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method
Bianca Posocco, Martina Zanchetta, Marco Orleni, et al.
Journal of Minimally Invasive Gynecology
|
October 20, 2009
Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report
Massimiliano Fambrini, Gianni Bargelli, Elena Peruzzi, et al.
Frontiers in Pharmacology
|
September 23, 2024
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions
Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, et al.
International Journal of Molecular Sciences
|
October 16, 2024
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring
Eleonora Cecchin, Marco Orleni, Sara Gagno, et al.
Menopause (New York, N.Y.)
|
June 7, 2003
Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women
Alessandro Rubinacci, Elena Peruzzi, Alberto Bacchi Modena, et al.
International Journal of Cancer
|
June 10, 2026
DPYD and UGT1A1 Genotype-Based Dosing for Fluoropyrimidines and Irinotecan Chemotherapy: Variant-Specific Impact on Treatment Intensity and Toxicity
Martina Gambron, Elena Peruzzi, Samantha Perfler, et al.
Page
of 3